Literature DB >> 3275561

Effects of the protein matrix on glycan processing in glycoproteins.

M G Yet1, M C Shao, F Wold.   

Abstract

In the biosynthesis of glycoproteins containing asparagine-linked glycans, a number of regulatory factors must be involved in converting the single glycan precursor into the variety of different final structures observed in different eukaryotic species. Among these factors are the kind of glycan-processing enzymes available in the Golgi apparatus of different cells, the specificity and regulatory properties of these enzymes, and the unique properties of the protein matrix in which a given glycan resides during the biosynthetic processing. In examining the role of this latter regulatory factor, we have considered a simplified model in which a few key steps are common to all cells, regardless of the nature of the processing enzymes available. The protein-bound oligomannose precursor Man8GlcNAc2-, arriving in the Golgi after the initial trimming in the endoplasmic reticulum (ER), first undergoes a series of preprocessing steps to yield Man5GlcNAc2- in animals and plants or Man13-15GlcNAc2- in yeast. At this stage the key commitment step--to process or not to process--determines whether the above intermediates will remain as unprocessed oligomannose structures or be initiated into a new series of reactions to yield processed structures characteristic of the organisms involved (complex or hybrid for vertebrates, polymannose for yeast, xylosylated glycans for plants and some invertebrates, or Man3GlcNAc2- structures for other invertebrates). It is proposed that this commitment step, along with the obligatory preprocessing steps, is regulated primarily by each glycan's unique exposure on its protein matrix. Subsequent processing steps leading to complex or hybrid structures, fucosylation, extent of branching, and specific structures at the nonreducing terminals are most likely determined primarily by the enzyme makeup of the individual processing machineries, but with the protein matrix still playing a significant role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275561     DOI: 10.1096/fasebj.2.1.3275561

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.

Authors:  M J Treuheit; C E Costello; H B Halsall
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Comparative study of the glycosylation of platelet glycoprotein GPIIb/IIIa and the vitronectin receptor. Differential processing of their beta-subunit.

Authors:  A Troesch; A Duperray; B Polack; G Marguerie
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

3.  Enhanced detection and identification of glycopeptides in negative ion mode mass spectrometry.

Authors:  Charles C Nwosu; John S Strum; Hyun Joo An; Carlito B Lebrilla
Journal:  Anal Chem       Date:  2010-11-04       Impact factor: 6.986

4.  Targeting and glycosylation of patatin the major potato tuber protein in leaves of transgenic tobacco.

Authors:  U Sonnewald; A Sturm; M J Chrispeels; L Willmitzer
Journal:  Planta       Date:  1989-09       Impact factor: 4.116

Review 5.  Subunit assembly and functional maturation of Na,K-ATPase.

Authors:  K Geering
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

6.  Simultaneous and extensive site-specific N- and O-glycosylation analysis in protein mixtures.

Authors:  Charles C Nwosu; Richard R Seipert; John S Strum; Serenus S Hua; Hyun Joo An; Angela M Zivkovic; Bruce J German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2011-04-21       Impact factor: 4.466

7.  Complementation of an Arabidopsis thaliana mutant that lacks complex asparagine-linked glycans with the human cDNA encoding N-acetylglucosaminyltransferase I.

Authors:  L Gomez; M J Chrispeels
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

8.  Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody.

Authors:  T P Patel; R B Parekh; B J Moellering; C P Prior
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.

Authors:  Andrew J Borst; Connor E Weidle; Matthew D Gray; Brandon Frenz; Joost Snijder; M Gordon Joyce; Ivelin S Georgiev; Guillaume Be Stewart-Jones; Peter D Kwong; Andrew T McGuire; Frank DiMaio; Leonidas Stamatatos; Marie Pancera; David Veesler
Journal:  Elife       Date:  2018-11-07       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.